Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

NCT07338331 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Diabete Type 2
Non Alcoholic Fatty Liver

Interventions

DRUG: Aspirin
DRUG: Dapagliflozin (10Mg Tab) along with standard medical therapy

Sponsor

Galala University